All analyses
AI analysis

Maskeliya Plantations Plc: research report

UndervaluedneutralNov 13, 2026

Evidence is evenly balanced: MASK scores 94 of 100 on exchange-wide value and had no debt at its last year-end. The catch is September net profit fell 85.8% year-on-year.

Reports without a focus are public, one per stock per day. Generation usually takes about 15 minutes, and we'll notify you when it's ready.

Why balanced

  • It scores 94 of 100 on price against filed book value, earnings and dividends, placing it in the exchange's Undervalued band.
  • The March 2026 year-end balance sheet had zero debt and generated a 22.2% return on equity.

Against this. September-quarter net profit fell 85.8% year-on-year as operating margin fell to 4.0%, the worst of five comparable September quarters.

Operating margin
4.0%sector 4.3%
from 14.3% a year earlier
Net margin
1.4%sector 2.8%
from 9.5% a year earlier, revenue -7.0%
Return on equity
15.5%
twelve months to Sep 30, 2026, unaudited
P/E
7.3sector 9.5
earnings Rs 9.07 per share, year to Sep 2026
P/B
1.13sector 1.14
book Rs 58.33 per share
Dividend yield
6.06%sector 2.20%
44.1% of earnings paid out

Current figures, updated daily from filings to Sep 30, 2026. The report below was written on Nov 13, 2026. Sector figures are the median of 25 listed companies in the same sector.

Overview

Maskeliya Plantations cultivates, manufactures and sells tea from 18 estates and 15 processing centres, with smaller exposure to timber and high-value crops. The latest September quarter marked a sharp deterioration in profitability as revenue and tea-processing margins weakened, offsetting a balance sheet that had improved substantially by the March year-end.

Price performance

At LKR 63.90 on 13 November 2026, MASK was down 38.9% over one year against a 4.7% fall in the ASPI, a substantial company-specific divergence not explained by material company news in the dataset. The share sat only 10.4% of the way up its 52-week range, close to its annual low.

Recent annualised volatility was 16.3% above its own one-year norm, so trading has become more variable than MASK's recent history. The three-year record shows two falls of 15% or more, the deepest 50%, which has not yet recovered. Liquidity is a material constraint: a LKR 1 million order is more than everything that trades on a typical day (639% of it).

Valuation

The P/E is 5.2 times, meaning the market price is LKR 5.20 for each LKR 1 of trailing profit, and sits at the 5th percentile of sector peers. The P/B is 1.1 times, or LKR 1.10 for each LKR 1 of net assets, while the latest audited return on equity was 22.2%; that profitability helps explain why the shares trade modestly above book value.

The 6.3% dividend yield is above three quarters of sector peers, but the recorded payment eased to LKR 4.00 in FY2026 from LKR 4.50 in FY2025. Against its own record, the P/E is more expensive than 62% of days since February 2012 and P/B is more expensive than 64% of days since February 2012, so the sector discount is not a discount to MASK's own typical trading history.

A buyer at this price is relying little on the latest quarter: it supplied 5.3% of trailing EPS. However, its 1.4% net margin was well below the year-ago 9.4%, and applying that earlier margin to the same quarter would reduce the P/E to 4.1 times.

News and sentiment

Direct company coverage is thin, with no material articles recorded in the last 90 days. The LKR 4.00 FY2026 interim dividend went ex on 10 April 2026, so a buyer today does not receive it.

Financials

The September 2026 quarter weakened against the prior September: revenue fell 7.0%, operating profit fell 74.2%, and net profit fell 85.8% to LKR 24.6 million. This means the profit behind the share price was much smaller even before considering the lower sales base.

Gross margin fell from 18.1% to 5.7%, operating margin from 14.3% to 4.0%, and net margin from 9.4% to 1.4%. The operating margin was the worst of five comparable September quarters, showing that the pressure was unusually severe even after comparing the same point in the annual cycle. Finance costs, tax and other non-operating items removed LKR 43.3 million from operating profit, leaving little of the LKR 67.9 million operating result for shareholders.

Equity rose to LKR 3.1 billion from LKR 3.0 billion a year earlier, while the share count was essentially unchanged at 54.0 million. The latest audited full year ended March 2026, rather than the September interim period, and recorded a 31.3% decline in net profit despite 5.0% revenue growth.

Risks

The largest immediate risk is that the September margin collapse persists: the company made only 1 cent of net profit on each rupee of sales, versus 9 cents a year earlier. The data does not identify a company-specific cause, but the plantation-sector backdrop as at 13 November 2026 includes higher fuel costs and a 3% fall in national tea output during the first seven months of 2026.

Balance-sheet risk is currently contained. At the March 2026 year-end, gearing was 0.0%, meaning there was no debt against owners' equity, and operating profit covered interest costs 10.6 times. The current ratio was 1.45 times, meaning short-term assets, including inventories and customer receivables, exceeded bills due within a year. Cash conversion was 0.81 times, so not all operating profit arrived as operating cash during that audited year.

Outlook

As at 13 November 2026, the next decisive event is the December 2026 interim quarter, expected to be filed between 5 and 14 February 2027. It will show whether the September margin compression extended into the following quarter or was confined to that period; current data cannot distinguish between those outcomes.

The plantation environment also bears watching because sector-wide fuel-cost pressure can affect estate operating costs, while trade-facilitation measures may improve export administration. Neither backdrop item establishes a direct financial effect on MASK.

About this report. Generated on Nov 13, 2026 from market data up to Nov 13, 2026, 0 material news articles over 90 days and financials to Sep 30, 2026, and scored 94 of 100 on value (undervalued) when it was written. Every figure is drawn from EquityLK's own data on this company. AI research can contain errors, so treat it as a starting point, not investment advice.

Previous reports